ECTRIMS 2015 Barcelona

Image for ECTRIMS 2015 Barcelona

Centre de Convencions Internacional in Barcelona during ECTRIMS 2015.

Let's meet ...

5 Oct 2015  |  News  |  Events

Dr Wolf attends the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 6-10 October 2015 at the Centre de Convencions Internacional in Barcelona.

Programme

Dr Wolf co-authored 3 posters:

  • F Barkhof, A Belova, K Selmaj, C Wolf, ERW van den Tweel, JJL Oberyé, R Mulder, NP Koper, JA Cohen, on behalf of the GATE Study Group
    Switching from branded to generic glatiramer acetate: two-year MRI data from the GATE trial demonstrates continuous efficacy.
    P522 (full text).
  • H. Wiendl, F. Dahlke, D. Bennett, G. Rosenkranz, C. Wolf, A. Bar-Or.
    IL-17 neutralization by subcutaneous CJM112, a fully human anti IL-17A monoclonal antibody for the treatment of relapsing-remitting multiple sclerosis: study design of a phase 2 trial.
    P655 (full text).
  • JA Cohen, A Belova, F Barkhof, C Wolf, ERW van den Tweel, JJL Oberyé, R Mulder, NP Koper, K Selmaj, on behalf of the GATE Study Group
    Switching from branded to generic glatiramer acetate: two-year clinical data from the GATE trial further support the continued efficacy and tolerability of generic glatiramer.
    P1050 (full text).